Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
. 2020 Jul 3;19(8):1826–1827. doi: 10.1111/jocd.13520

The aftermath of COVID‐19 in dermatology practice: What's next?

Janice Natasha Ng 1, Kathryn Anne G Cembrano 1, Rungsima Wanitphakdeedecha 1, Woraphong Manuskiatti 1,
PMCID: PMC7301026  PMID: 32502318

Abstract

The rapidly increasing number of COVID‐19‐infected patients and evidence of human‐to‐human transmission even within the asymptomatic incubation period prompted the attention of the entire world. The field of dermatology and procedural dermatology is not exempt from this global issue. We cannot deny the fact that this situation will have a lasting impact on the health‐seeking behaviors of our patients. It is necessary for dermatologists and dermatologic surgeons to be aware of the potential risks and precautions when re‐emerging their practices after COVID‐19.

Keywords: COVID‐19, dermatology, healthcare workers, new normal, teledermatology


On March 11, 2020, the World Health Organization (WHO) declared the coronavirus disease (COVID‐19) outbreak a pandemic, with an estimated number of 118 000 positive cases in over 110 countries around the world, and a threat of further global spread. 1 The increasing number of confirmed COVID‐19‐infected cases emphasized the importance of preventive measures among healthcare workers (HCWs). 2 The practice of dermatology was not exempt from this global issue since most clinics rescheduled all outpatient visits except for urgent and essential cases to decrease the risk of exposure.

As the medical world tries to find promising solutions to fight COVID‐19, what active role can we as dermatologists play in the battle against this pandemic? There is sufficient information on clinical practice guidelines from the WHO, Centers for Disease Control and Prevention (CDC), and medical societies that we can adapt in our own practice to enhance preventive measures. Recently, skin changes such as erythematous rash, widespread urticaria, and even varicella‐like vesicles were reported in COVID‐19‐infected patients. 3 These findings will definitely change our differential diagnoses in patients presenting with flu‐like symptoms and nonspecific viral exanthems. In an effort to better understand the cutaneous involvement of COVID‐19 and how it affects disease transmission, more published data from all over the world are needed.

Months or even years from now, even if the declaration of this pandemic is lifted, we cannot deny the fact that this situation will have a lasting impact on the health‐seeking behaviors of our patients. Everyone would still wear masks, practice social distancing, and only limit going out to do essential errands.

Teledermatology has offered us a convenient way of providing dermatological consultations while minimizing the risks of infection. Recently, there is a published guideline for adapting teledermatology into the practice during the pandemic. 4 The challenges behind this technology include technical problems (poor internet connection) and the possibility of misdiagnosis due to incomplete history taking, poor quality photographs, and inability to perform the usual diagnostic procedures. In addition, security breaches in online platforms are a rising concern and some patients may not be comfortable in revealing sensitive areas of their bodies through a webcam. Patient confidentiality must be the utmost priority in teledermatology. For the time being, we can advise patients to take photographs with good lighting conditions and different angles (ideally one photograph showing the lesions in relation to the whole body and another close‐up view showing the morphology of the lesion) as well. Online skin care prescriptions with delivery can also be a good alternative for patients to stay on track with their treatment regimens.

There is a far greater impact to those performing aesthetic procedures since these are considered nonessential services for the time being. A lot of patients will likely come back for their maintenance treatments once the pandemic has been lifted, but we must proceed with caution and continue to practice the use of enhanced personal protective equipment in all procedures. There is a high chance of contracting or even transmitting the disease because of the close distance maintained while performing laser and dermatologic procedures or injecting toxins or fillers. The use of appropriate goggles, masks, face shields, gloves, and smoke evacuators are essential in current clinical practice. 5

This pandemic has caused the whole world to go through an economic recession. How can we get back on our feet once the situation is under control? This is really a great unforeseen business risk particularly for dermatologists in private practice. The importance of medical business education cannot be further emphasized given this situation. Almost all dermatology clinics are dealing with overhead and salary costs despite the decline in operational revenue because of the government‐mandated lockdowns. It is not unusual to encounter staff lay‐offs during this period, and in order to prevent this, we should make a few changes in our business operations such as those mentioned above. After this pandemic, patients will likely be more cautious in consulting for aesthetic concerns; thus, we can provide educational material regarding the preventive measures for disease transmission in our practice.

In summary, transitioning to this “new normal” is the best way to cope with the current situation. We may or may not need to adapt teledermatology permanently into our practice. The economic aftermath of this situation is beyond imaginable, but we must ethically balance our income generating activities while ensuring patient safety. We are facing many unknowns, but we hope to emerge as a stronger medical front alongside our colleagues from other specialties in rising above this pandemic.

CONFLICT OF INTEREST

None.

Ng JN, Cembrano KAG, Wanitphakdeedecha R, Manuskiatti W. The aftermath of COVID‐19 in dermatology practice: What's next?. J Cosmet Dermatol. 2020;19:1826–1827. 10.1111/jocd.13520

REFERENCES

  • 1. Ghebreyesus TA, WHO Director‐General’s opening remarks at the media briefing on COVID‐19‐11 March 2020. World Health Organization. 2020.
  • 2. Zhang Z, Liu S, Xiang M, et al. Protecting healthcare personnel from 2019‐nCoV infection risks: lessons and suggestions. Front Med. 2020;14(2):229‐231. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Recalcati S. Cutaneous manifestations in COVID‐19: a first perspective. J Eur Acad Dermatol Venereol. 2020.34(5):e212–e213. [DOI] [PubMed] [Google Scholar]
  • 4. Lee I, Kovarik C, Tejasvi T, Pizarro M, Lipoff JB. Telehealth: helping your patients and practice survive and thrive during the COVID‐19 crisis with rapid quality implementation. J Am Acad Dermatol. 2020;82(5):1213‐1214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Adhikari SP, Meng S, Wu YJ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID‐19) during the early outbreak period: a scoping review. Infect Dis Poverty. 2020;9:29. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Cosmetic Dermatology are provided here courtesy of Wiley

RESOURCES